Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The treatment has been around for decades, but has had a rocky history: It was widely prescribed from the 1960s through 1990s before usage came to an abrupt halt in 2002, when the Womens Health Initiative published findings suggesting that hormone therapy increased the risk of breast cancer, heart disease, stroke, and blood clots
Similar results were also obtained by the Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial, where the long-term treatment with dulaglutide was also found to reduce the incidence of moderate or severe erectile dysfunction in middle-aged men with T2DM [155]
But one of the first questions providers ask is: When can I bill insurance for IV therapy? The answer depends on a combination of medical necessity, documentation, coding, and payer policy
Colombo says
